Research
Research Interest 1
Please see the Rannard Group website http://rannardgroup.wix.com/rannardgroup for full details of our current research, archives of our publications and current vacancies.
The group researches novel polymer chemistry and organic nanoparticle production for many potential applications including nanomedicine. Within our nanomedicine programmes, we are highly focussed on infectious diseases including HIV, where our outputs are targeting clinically relevant translational technologies.
Research groups
Research grants
Novel fire retardant and curing resins
SCOTT BADER (UK)
November 2019 - April 2023
Nanoparticle processing and development
TANDEM NANO LTD (UK)
April 2020 - May 2026
Bench Fees for May Hasan D Al Adwani (201534091)
ROYAL EMBASSY OF SAUDI ARABIA CULTURAL BUREAU IN LONDON (UK)
April 2021 - September 2024
New Branched Polymers Excipients and Emulsions for Enhanced Drug Delivery
ENGINEERING & PHYSICAL SCIENCES RESEARCH COUNCIL
July 2018 - June 2023
New Polymers from Multi-Vinyl Monomer Homopolymerisation
ENGINEERING & PHYSICAL SCIENCES RESEARCH COUNCIL
November 2017 - October 2021
Long acting NRTI therapies for HIV
NATIONAL INSTITUTES OF HEALTH (USA)
July 2017 - June 2023
An Injectable Implant Providing Long-Acting Drug Delivery for the Treatment of Chronic disease
ENGINEERING & PHYSICAL SCIENCES RESEARCH COUNCIL
April 2019 - April 2023
In vitro and in vivo assessment of nanoemulsion co-formulations of dolutegravir and rilpivirine.
BRITISH SOCIETY FOR ANTIMICROBIAL CHEMOTHERAPY (UK)
June 2017 - December 2018
Sustained, injectable ocular drug delivery systems
ENGINEERING & PHYSICAL SCIENCES RESEARCH COUNCIL
October 2018 - June 2023
DTP Studentship - Industry Top-Up
ITACONIX LTD (UK)
October 2017 - September 2021
Evaluating biosubstrate triggered emulsions for step change product design and development
INNOVATE UK (UK)
April 2017 - April 2018
Croda Branched Polymers
CRODA (UK)
March 2018 - March 2019
Nanoengineered microneedle arrays for enhanced delivery of long-acting HIV medicines
ENGINEERING & PHYSICAL SCIENCES RESEARCH COUNCIL
August 2019 - July 2022
EPSRC Institutional Sponsorship 2016
ENGINEERING & PHYSICAL SCIENCES RESEARCH COUNCIL
July 2016 - March 2017
European Nanotechnology Characterisation Laboratory
EUROPEAN COMMISSION
May 2015 - December 2019
Nanoparticle Interventions for Colorectal Cancer
CANCER RESEARCH UK (UK)
October 2016 - September 2021
Antiretroviral therapy (ART) simplification
WITS REPRODUCTIVE HEALTH & HIV INSTITUTE (S AFRICA)
October 2015 - October 2020
Development of solid drug nanoparticle for treatment of mycobacterium tuberculosis
NATIONAL INSTITUTES OF HEALTH (USA)
October 2013 - December 2013
Towards NanoMedicine Interventions for HIV/AIDS
ENGINEERING & PHYSICAL SCIENCES RESEARCH COUNCIL
May 2012 - November 2016
Integrated radiomaterials chemistry for simultaneous multi-component tracking of nanomedicines in biological matrices
ENGINEERING & PHYSICAL SCIENCES RESEARCH COUNCIL
September 2014 - March 2018
Pickering-stabilised Nanoemulsions as Novel Antiretroviral Drug Delivery Systems
BRITISH SOCIETY FOR ANTIMICROBIAL CHEMOTHERAPY (UK)
October 2009 - September 2013
Royal Society Industry Fellowship - Transfer from Unilever
ROYAL SOCIETY
September 2007 - June 2009
Application of nanomedicine to childhood diseases.
ALDER HEY CHILDREN'S NHS FOUNDATION TRUST (UK)
October 2013 - September 2016
New Nanoscale Drug Delivery Systems and their Application to HIV/AIDS treatment
ENGINEERING & PHYSICAL SCIENCES RESEARCH COUNCIL
November 2011 - April 2016
Non-Attrition HAART nanoparticle therapies for HIV/AIDS Drug Delivery
ENGINEERING & PHYSICAL SCIENCES RESEARCH COUNCIL
May 2009 - October 2012
Towards complete sustained release nanoformulations of NRTI based regimens
NATIONAL INSTITUTES OF HEALTH (USA)
July 2014 - June 2019
Liverpool Imaging Partnership: Molecular physiology and drug response
MEDICAL RESEARCH COUNCIL
February 2013 - February 2017